[go: up one dir, main page]

ZA201504817B - Hiv-1 env-binding antibodies, fusion proteins, and methods of use - Google Patents

Hiv-1 env-binding antibodies, fusion proteins, and methods of use

Info

Publication number
ZA201504817B
ZA201504817B ZA2015/04817A ZA201504817A ZA201504817B ZA 201504817 B ZA201504817 B ZA 201504817B ZA 2015/04817 A ZA2015/04817 A ZA 2015/04817A ZA 201504817 A ZA201504817 A ZA 201504817A ZA 201504817 B ZA201504817 B ZA 201504817B
Authority
ZA
South Africa
Prior art keywords
env
hiv
methods
fusion proteins
binding antibodies
Prior art date
Application number
ZA2015/04817A
Inventor
Yongjun Guan
George Lewis
Anthony Devico
Mohammad Sajadi
Tongyun Liu
Marzena Pazgier
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/073003 external-priority patent/WO2014089152A1/en
Application filed by Univ Maryland filed Critical Univ Maryland
Publication of ZA201504817B publication Critical patent/ZA201504817B/en

Links

ZA2015/04817A 2012-12-04 2015-07-03 Hiv-1 env-binding antibodies, fusion proteins, and methods of use ZA201504817B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261733172P 2012-12-04 2012-12-04
US201361886370P 2013-10-03 2013-10-03
PCT/US2013/073003 WO2014089152A1 (en) 2012-12-04 2013-12-04 Hiv-1 env-binding antibodies, fusion proteins, and methods of use
PT57195216 2016-10-18

Publications (1)

Publication Number Publication Date
ZA201504817B true ZA201504817B (en) 2019-01-30

Family

ID=67107255

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2015/04817A ZA201504817B (en) 2012-12-04 2015-07-03 Hiv-1 env-binding antibodies, fusion proteins, and methods of use

Country Status (1)

Country Link
ZA (1) ZA201504817B (en)

Similar Documents

Publication Publication Date Title
IL286784A (en) Antibody and protein formulations
PT3744835T (en) Dna modifying fusion proteins and methods of use thereof
ZA201501858B (en) Anti-mcam antibodies and associated methods of use
ZA201407927B (en) Anti-egfr antibodies and uses thereof
IL236933A0 (en) Interleukin-2 fusion proteins and uses thereof
ZA201405864B (en) Cd47 antibodies and methods of use thereof
IL236838A0 (en) Anti-dengue virus antibodies and uses thereof
IL240034A0 (en) Pd-l1 and pd-l2-based fusion proteins and uses thereof
IL229753A0 (en) Fusion proteins releasing relaxin and uses thereof
IL238227A0 (en) Anti-c16orf54 antibodies and methods of use thereof
HUE053545T2 (en) Human immunodeficiency virus neutralizing antibodies and methods for their use
PT3489254T (en) Targeted/immunomodulatory fusion proteins and methods for making same
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
CL2015001266A1 (en) Antihemagglutinin antibodies and methods of use.
ZA201405554B (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
BR112015003032A2 (en) anti-jagged antibodies and methods of use '.
PL2869837T3 (en) Anti-theophylline antibodies and methods of use
PT2804875T (en) Tools and methods for expression of membrane proteins
ZA201504817B (en) Hiv-1 env-binding antibodies, fusion proteins, and methods of use
IL239671A0 (en) Stable form of signal converting protein fusion proteins, and methods of use and preparation thereof
AU2012901619A0 (en) Fusion Proteins and Use Thereof
AU2011902431A0 (en) Fusion Proteins and Use Thereof
AU2013901331A0 (en) Fusion Proteins and Use Thereof